Cytologic screening for cancer of the uterine cervix in Sweden evaluated by identification and simulation
- PMID: 2372495
- PMCID: PMC1971706
- DOI: 10.1038/bjc.1990.202
Cytologic screening for cancer of the uterine cervix in Sweden evaluated by identification and simulation
Abstract
Parameters characterising the progression of cervical neoplasia were estimated from population-based cancer and mortality statistics in Sweden for 1958-1981 by means of a dynamic computer model. Proceeding from that model and these data, the incidence and prevalence curves were constructed, the effects of the extensive cytological screening measures introduced during the 1960s were assessed, and future gains due to the measures already undertaken up to 1981 could be simulated. About 4,000 cases of cancer in situ were diagnosed annually in Sweden after the end of the 1960s, most of them in women born later than 1919. The maximum reduction in the number of invasive cancers up to 1981 was 42% for women born in 1919-1923, but increased progressively for later birth cohorts and reached 69% for those born in 1934-1938. The corresponding reduction in mortality rates was of the same magnitude. The screening measures up to 1981 will ultimately result in a reduction of invasive cancer by about 12,500 cases and of the number of deaths due to this disease by about 4,100. Only a part of the total gain in the number of lives saved had been revealed at the end of the study period in 1981.
Similar articles
-
Mass screening in Sweden for cancer of the uterine cervix: effect on incidence and mortality. An overview.Gynecol Obstet Invest. 1986;22(2):57-63. doi: 10.1159/000298892. Gynecol Obstet Invest. 1986. PMID: 3770533
-
Natural history of cervical neoplasia: consistent results obtained by an identification technique.Br J Cancer. 1989 Jul;60(1):132-41. doi: 10.1038/bjc.1989.236. Br J Cancer. 1989. PMID: 2803910 Free PMC article.
-
Evaluation of screening for cervical cancer in Sweden: trends in incidence and mortality 1958-1980.Int J Epidemiol. 1985 Dec;14(4):521-7. doi: 10.1093/ije/14.4.521. Int J Epidemiol. 1985. PMID: 4086138
-
Cervical cancer screening. Past success and future challenge.Prim Care. 1992 Sep;19(3):589-606. Prim Care. 1992. PMID: 1410065 Review.
-
Screening for cancer of the cervix in elderly women.Lancet. 1990 Jan 13;335(8681):97-9. doi: 10.1016/0140-6736(90)90552-g. Lancet. 1990. PMID: 1967429 Review.
Cited by
-
When Life Got in the Way: How Danish and Norwegian Immigrant Women in Sweden Reason about Cervical Screening and Why They Postpone Attendance.PLoS One. 2015 Jul 9;10(7):e0107624. doi: 10.1371/journal.pone.0107624. eCollection 2015. PLoS One. 2015. PMID: 26158449 Free PMC article.
-
Immigrant women's experiences and views on the prevention of cervical cancer: a qualitative study.Health Expect. 2015 Jun;18(3):344-54. doi: 10.1111/hex.12034. Epub 2012 Dec 16. Health Expect. 2015. PMID: 23252449 Free PMC article.
-
Co-testing in cervical screening among 40- to 42-year-old women is unreasonable.Acta Obstet Gynecol Scand. 2022 Mar;101(3):374-378. doi: 10.1111/aogs.14311. Epub 2022 Jan 5. Acta Obstet Gynecol Scand. 2022. PMID: 34988970 Free PMC article.
-
Cervix cytology samples revealed increased methylation of the human markers FAM19A4/miR124-2 up to 8 years before adenocarcinoma.Acta Obstet Gynecol Scand. 2024 Feb;103(2):378-386. doi: 10.1111/aogs.14707. Epub 2023 Nov 14. Acta Obstet Gynecol Scand. 2024. PMID: 37964497 Free PMC article.
-
Low risk of cervical cancer during a long period after negative screening in the Netherlands.Br J Cancer. 2003 Apr 7;88(7):1054-7. doi: 10.1038/sj.bjc.6600843. Br J Cancer. 2003. PMID: 12671704 Free PMC article.